Dr. Emily Slotkin, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Sarcoma
Studies Desmoplastic Small Round Cell Tumor
13 reported clinical trials
21 drugs studied
Area of expertise
1Sarcoma
Stage IV
Stage III
EWSR1
2Desmoplastic Small Round Cell Tumor
Stage III
Stage IV
EWSR1
Affiliated Hospitals
Clinical Trials Emily Slotkin, MD is currently running
Multiple Drug Therapies
for Cancer in Children and Young Adults
This trial tests new cancer drugs to see if they help patients and how long the benefits last. It focuses on different types of cancer and adds new studies as new drugs are developed.
Recruiting1 award Phase 2
GD2-SADA:177Lu-DOTA Complex
for Small Cell Lung Cancer
This trial tests a new treatment for certain cancers using a two-part method. The first part finds and attaches to cancer cells, and the second part delivers radiation to kill them. It aims to see if this treatment is safe and can be tolerated by patients with Small Cell Lung Cancer, Sarcoma, and Malignant Melanoma.
Recruiting1 award Phase 19 criteria
More about Emily Slotkin, MD
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Emily Slotkin, MD has experience with
- Ramucirumab
- Gemcitabine
- Irinotecan
- Docetaxel
- Cyclophosphamide
- Vinorelbine
Breakdown of trials Emily Slotkin, MD has run
Sarcoma
Desmoplastic Small Round Cell Tumor
Tumors
Ewing Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Slotkin, MD specialize in?
Emily Slotkin, MD focuses on Sarcoma and Desmoplastic Small Round Cell Tumor. In particular, much of their work with Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Emily Slotkin, MD currently recruiting for clinical trials?
Yes, Emily Slotkin, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Emily Slotkin, MD has studied deeply?
Yes, Emily Slotkin, MD has studied treatments such as Ramucirumab, Gemcitabine, Irinotecan.
What is the best way to schedule an appointment with Emily Slotkin, MD?
Apply for one of the trials that Emily Slotkin, MD is conducting.
What is the office address of Emily Slotkin, MD?
The office of Emily Slotkin, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.